Table 4.
Prior to procedure: | ||
Withhold for 48 h | Long-acting calcium antagonists | |
Withhold for 24 h | Caffeine | |
Long-acting nitrates | ||
Short-acting calcium antagonists | ||
α-Blockers | ||
β-Blockers | ||
ACE inhibitor | ||
Angiotensin receptor blockers | ||
Renin inhibitors | ||
Aldosterone inhibitors | ||
Withhold for 4 h | Sublingual nitrates | |
During procedure: | ||
Agent | Administration | Dose |
– Acetylcholine | Intracoronary (manual) bolus injection | LCA: 20/50/100/200 µg RCA: 20/50/80 µg over 20 s with an at least 3‑min interval between each injection |
Intracoronary (continuous) infusion | LCA or RCA: Incremental doses of 0.288/2.88/28.8/288 µg during 3 min (maximal highest dose 864 µg) | |
– Ergonovine | Intracoronary (continuous) infusion | LCA: 16 µg/min during 4 min (maximal dose 64 µg) RCA: 10 µg/min during 4 min (maximal dose 40 µg) |
Intravenous (continuous) infusion | Incremental doses of 50/100/150 µg during 5 min |
ACE angiotensin-converting-enzyme, LCA left coronary artery, RCA right coronary artery